发明名称 |
FIBROBLAST GROWTH FACTOR MUTANTS HAVING IMPROVED FUNCTIONAL HALF-LIFE AND METHODS OF THEIR USE |
摘要 |
Mutant fibroblast growth factor (FGF) proteins having a polypeptide sequence with a high sequence identity to proteins encoded by members of the Fgf-1 subfamily of genes from a mammalian species, such as human, and with a specific amino acid substitution of an alanine at a position corresponding to amino acid position 66 of human FGF-1 with a cysteine and/or a specific amino acid substitution of a phenylalanine at a position corresponding to amino acid position 132 of human FGF-1 with a tryptophan (based on the 140 amino acid numbering scheme of human FGF-1) are provided. Other amino acid mutations or substitutions may be combined. Polynucleotide sequences encoding the mutant FGF proteins and host cells containing such polynucleotide sequences are provided. Methods of administering a mutant FGF protein to an individual to treat an ischemic condition or disease or a wound or tissue injury are also provided. |
申请公布号 |
US2017096464(A1) |
申请公布日期 |
2017.04.06 |
申请号 |
US201615295804 |
申请日期 |
2016.10.17 |
申请人 |
Florida State University Research Foundation, Inc. |
发明人 |
Blaber Michael;LEE Jihun |
分类号 |
C07K14/50 |
主分类号 |
C07K14/50 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition comprising a mutant fibroblast growth factor (FGF) protein having a polypeptide sequence that is at least 90% identical to the wild-type human FGF-1 protein having SEQ ID NO: 1, the alanine at an amino acid position of the mutant FGF polypeptide sequence corresponding to amino acid position 66 of SEQ ID NO: 1 being substituted with cysteine, the mutant FGF protein have a greater functional half-life than SEQ ID NO: 1. |
地址 |
Tallahassee FL US |